Download
s11262-021-01871-8.pdf 1,24MB
WeightNameValue
1000 Titel
  • Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
1000 Autor/in
  1. Müller, Katharina |
  2. Girl, Philipp |
  3. Giebl, Andreas |
  4. Gruetzner, Stefanie |
  5. Antwerpen, Markus |
  6. Khatamzas, Elham |
  7. Wölfel, Roman |
  8. von Buttlar, Heiner |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-10-04
1000 Erschienen in
1000 Quellenangabe
  • 57(6):502-509
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11262-021-01871-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489549/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • SARS-CoV-2 infections elicit a humoral immune response capable of neutralising the virus. However, multiple variants have emerged with mutations in the spike protein amongst others, the key target of neutralising antibodies. We evaluated the neutralising efficacy of 89 serum samples from patients, infected with SARS-CoV-2 in the beginning of 2020, against two virus variants isolated from acutely infected patients and harbouring spike protein mutations. One isolate was assigned to lineage B.1.351 (MUC-IMB-B.1.351) whilst the other (MUC-484) was isolated from an immunocompromised patient, sharing some but not all mutations with B.1.351 and representing a transitional variant. Both variants showed a significant reduction in neutralisation sensitivity compared to wild-type SARS-CoV-2 with MUC-IMB-B.1.351 being almost completely resistant to neutralisation. The observed reduction in neutralising activity of wild-type-specific antibodies against both variants suggests that individual mutations in the spike protein are sufficient to confer a potent escape from the humoral immune response. In addition, the effect of escape mutations seems to accumulate, so that more heavily mutated variants show a greater loss of sensitivity to neutralisation up to complete insensitivity as observed for MUC-IMB-B.1.351. From a clinical point of view, this might affect the efficacy of (monoclonal) antibody treatment of patients with prolonged infections as well as patients infected with variants other than the donor. At the same, this could also negatively influence the efficacy of current vaccines (as they are based on wild-type spike protein) emphasising the need to thoroughly surveil the emergence and distribution of variants and adapt vaccines and therapeutics accordingly.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Antibodies, Viral/immunology [MeSH]
lokal Mutation [MeSH]
lokal COVID-19/immunology [MeSH]
lokal COVID-19/virology [MeSH]
lokal Antibodies, Monoclonal/therapeutic use [MeSH]
lokal Antibodies, Monoclonal/immunology [MeSH]
lokal Humans [MeSH]
lokal SARS-CoV-2/genetics [MeSH]
lokal Antibodies, Neutralizing/therapeutic use [MeSH]
lokal COVID-19
lokal Spike Glycoprotein, Coronavirus/genetics [MeSH]
lokal Antibodies, Neutralizing/immunology [MeSH]
lokal Mutation E484K
lokal SARS-CoV-2/immunology [MeSH]
lokal Antibodies, Viral/therapeutic use [MeSH]
lokal Original Paper
lokal SARS-CoV-2/chemistry [MeSH]
lokal B.1.351
lokal Neutralising antibodies
lokal SARS-CoV-2
lokal Immune escape
lokal Variants of concern
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgS2F0aGFyaW5h|https://orcid.org/0000-0003-1370-4114|https://frl.publisso.de/adhoc/uri/R2llYmwsIEFuZHJlYXM=|https://frl.publisso.de/adhoc/uri/R3J1ZXR6bmVyLCBTdGVmYW5pZQ==|https://frl.publisso.de/adhoc/uri/QW50d2VycGVuLCBNYXJrdXM=|https://frl.publisso.de/adhoc/uri/S2hhdGFtemFzLCBFbGhhbQ==|https://frl.publisso.de/adhoc/uri/V8O2bGZlbCwgUm9tYW4=|https://frl.publisso.de/adhoc/uri/dm9uIEJ1dHRsYXIsIEhlaW5lcg==
1000 Hinweis
  • DeepGreen-ID: 0e29225c3d014fd5afb4969c2e501cf0 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6444750.rdf
1000 Erstellt am 2023-04-27T14:19:07.430+0200
1000 Erstellt von 322
1000 beschreibt frl:6444750
1000 Zuletzt bearbeitet Fri Oct 20 13:52:52 CEST 2023
1000 Objekt bearb. Fri Oct 20 13:52:52 CEST 2023
1000 Vgl. frl:6444750
1000 Oai Id
  1. oai:frl.publisso.de:frl:6444750 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source